Neuland Laboratories, 524558, NEULANDLAB Share Price, Rating, Research, Analysis, Fundamental & Historical Data

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

16,923.01
65.06
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

16,800.20
0.09%
11.11

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

12.76
15.36
17.90

EBITDA CAGR (%)

10 Years
5 Years
3 Years

21.38
35.34
26.53

PAT CAGR (%)

10 Years
5 Years
3 Years

34.11
79.26
67.53

P:E (Median)

8 Years
5 Years
3 Years

32.47
29.08
26.83

P:BV (Average)

8 Years
5 Years
3 Years

3.99
4.84
6.46

EV:EBITDA (Average)

8 Years
5 Years
3 Years

17.17
18.74
21.89

Earnings Forecasts:

(Updated: 06-06-2025)

Description 2024 2025 2026 2027
Adj EPS 233.89 201.63 297.48 411.3
P/E Ratio 56.41 65.43 44.35 32.08
Revenue 1516 1477 1951 2412
EBITDA 463 323 579 780
Net Income 300 260 383 529
ROA 17.6 13
P/B Ratio 13.26 11.16 9.10 7.22
ROE 26.36 18.53 20.72 23.37
FCFF 112 113 232 331
FCFF Yield 0.8 0.81 1.66 2.37
Net Debt -21 -228
BVPS 994.97 1181.97 1449.64 1827.66

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 25 Mar 24 Var% Dec 24 Dec 23 Var% Sep 24 Sep 23 Var% Jun 24 Jun 23 Var%
Net Sales 328.36 385.01 -14.71% 398.03 392.83 1.32% 310.84 417.75 -25.59% 439.60 362.99 21.11%
Expenses 277.61 278.22 -0.22% 311.66 272.26 14.47% 249.50 280.45 -11.04% 315.78 265.73 18.83%
EBITDA 50.75 106.79 -52.48% 86.38 120.56 -28.35% 61.34 137.30 -55.32% 123.83 97.27 27.31%
EBIDTM 15.46% 27.74% 21.70% 30.69% 19.73% 32.87% 28.17% 26.80%
Other Income 7.46 5.36 39.18% 3.91 2.10 86.19% 4.33 3.05 41.97% 4.81 2.04 135.78%
Interest 2.35 3.61 -34.90% 2.22 3.74 -40.64% 1.06 4.43 -76.07% 2.67 2.21 20.81%
Depreciation 16.89 16.46 2.61% 16.30 15.14 7.66% 16.07 14.51 10.75% 16.28 13.59 19.79%
PBT 38.98 92.08 -57.67% 127.55 103.78 22.90% 48.54 121.41 -60.02% 130.31 83.50 56.06%
Tax 11.25 24.47 -54.03% 26.15 23.08 13.30% 16.58 32.34 -48.73% 31.97 21.28 50.23%
PAT 27.73 67.61 -58.99% 101.39 80.70 25.64% 31.96 89.06 -64.11% 98.34 62.22 58.05%
PATM 8.45% 17.56% 25.47% 20.54% 10.28% 21.32% 22.37% 17.14%
EPS 21.67 52.82 -58.97% 79.21 63.05 25.63% 24.97 69.58 -64.11% 76.83 48.61 58.05%

Description Mar 25 Mar 24 Var% Dec 24 Dec 23 Var% Sep 24 Sep 23 Var% Jun 24 Jun 23 Var%
Net Sales 328.36 385.01 -14.71% 398.03 392.83 1.32% 310.84 417.75 -25.59% 439.60 362.99 21.11%
Expenses 277.29 278.09 -0.29% 311.43 271.56 14.68% 248.62 280.26 -11.29% 316.24 266.07 18.86%
EBITDA 51.07 106.92 -52.24% 86.60 121.27 -28.59% 62.23 137.49 -54.74% 123.36 96.92 27.28%
EBIDTM 15.55% 27.77% 21.76% 30.87% 20.02% 32.91% 28.06% 26.70%
Other Income 7.46 5.36 39.18% 3.91 2.10 86.19% 4.33 3.05 41.97% 4.81 2.04 135.78%
Interest 2.35 3.61 -34.90% 2.22 3.74 -40.64% 1.06 4.43 -76.07% 2.67 2.21 20.81%
Depreciation 16.89 16.46 2.61% 16.30 15.14 7.66% 16.07 14.51 10.75% 16.28 13.59 19.79%
PBT 39.30 92.20 -57.38% 127.77 104.48 22.29% 49.42 121.59 -59.36% 129.84 83.16 56.13%
Tax 11.49 24.64 -53.37% 26.18 23.09 13.38% 16.58 32.35 -48.75% 31.97 21.28 50.23%
PAT 27.80 67.56 -58.85% 101.59 81.39 24.82% 32.84 89.25 -63.20% 97.87 61.88 58.16%
PATM 8.47% 17.55% 25.52% 20.72% 10.57% 21.36% 22.26% 17.05%
EPS 21.55 52.37 -58.85% 78.75 63.09 24.82% 25.46 69.18 -63.20% 75.86 47.96 58.17%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Net Sales 1,476.83 1,558.58 1,191.20 951.08 936.91 762.71 666.83 527.41 578.89 509.97 469.15 Net Sales Growth -5.25% 30.84% 25.25% 1.51% 22.84% 14.38% 26.43% -8.89% 13.51% 8.70% Cost Of Goods Sold 587.63 577.29 478.23 422.14 438.42 380.20 366.24 238.37 262.90 253.46 243.99 Gross Profit 889.20 981.30 712.97 528.94 498.50 382.51 300.59 289.04 315.99 256.52 225.16 GP Margin 60.21% 62.96% 59.85% 55.61% 53.21% 50.15% 45.08% 54.80% 54.59% 50.30% 47.99% Total Expenditure 1,154.55 1,096.66 919.89 808.88 790.47 661.25 608.96 477.38 473.20 430.10 402.79 Power & Fuel Cost - 48.72 48.62 42.21 39.21 32.75 26.81 25.95 25.78 22.24 22.53 % Of Sales - 3.13% 4.08% 4.44% 4.19% 4.29% 4.02% 4.92% 4.45% 4.36% 4.80% Employee Cost - 248.53 194.84 175.76 144.02 118.48 104.47 95.73 84.92 59.89 49.16 % Of Sales - 15.95% 16.36% 18.48% 15.37% 15.53% 15.67% 18.15% 14.67% 11.74% 10.48% Manufacturing Exp. - 107.79 86.94 89.16 77.10 64.84 50.10 55.54 44.90 39.31 43.56 % Of Sales - 6.92% 7.30% 9.37% 8.23% 8.50% 7.51% 10.53% 7.76% 7.71% 9.28% General & Admin Exp. - 57.05 48.24 34.50 37.42 25.18 24.56 30.38 25.23 26.90 20.77 % Of Sales - 3.66% 4.05% 3.63% 3.99% 3.30% 3.68% 5.76% 4.36% 5.27% 4.43% Selling & Distn. Exp. - 47.24 40.25 36.00 42.38 26.59 28.01 26.50 23.14 26.41 20.31 % Of Sales - 3.03% 3.38% 3.79% 4.52% 3.49% 4.20% 5.02% 4.00% 5.18% 4.33% Miscellaneous Exp. - 10.04 22.77 9.12 11.93 13.21 8.76 4.91 6.34 1.89 20.31 % Of Sales - 0.64% 1.91% 0.96% 1.27% 1.73% 1.31% 0.93% 1.10% 0.37% 0.53% EBITDA 322.30 461.92 271.31 142.20 146.44 101.46 57.87 50.03 105.69 79.87 66.36 EBITDA Margin 21.82% 29.64% 22.78% 14.95% 15.63% 13.30% 8.68% 9.49% 18.26% 15.66% 14.14% Other Income 20.51 12.54 9.75 2.08 16.09 3.89 3.49 4.53 1.17 1.62 0.78 Interest 8.30 14.00 13.07 13.49 17.90 21.57 15.66 18.92 21.08 24.47 27.35 Depreciation 65.54 59.70 52.78 49.04 39.68 31.28 25.86 22.10 19.23 15.74 15.32 PBT 345.38 400.77 215.21 81.74 104.96 52.50 19.84 13.54 66.55 41.28 24.48 Tax 85.95 101.17 52.09 18.21 24.67 36.62 3.69 1.73 20.17 14.87 8.70 Tax Rate 24.89% 25.24% 24.20% 22.28% 23.50% 69.75% 18.60% 12.78% 30.31% 36.02% 35.54% PAT 259.42 299.60 163.12 63.53 80.29 15.88 16.14 11.81 46.38 26.41 15.78 PAT before Minority Interest 259.42 299.60 163.12 63.53 80.29 15.88 16.14 11.81 46.38 26.41 15.78 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 17.57% 19.22% 13.69% 6.68% 8.57% 2.08% 2.42% 2.24% 8.01% 5.18% 3.36% PAT Growth -13.41% 83.67% 156.76% -20.87% 405.60% -1.61% 36.66% -74.54% 75.62% 67.36% EPS 202.67 234.06 127.44 49.63 62.73 12.41 12.61 9.23 36.23 20.63 12.33

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Net Sales 1,476.83 1,558.58 1,191.20 951.08 936.91 762.71 666.83 527.41 578.89 509.97 469.15 Net Sales Growth -5.25% 30.84% 25.25% 1.51% 22.84% 14.38% 26.43% -8.89% 13.51% 8.70% Cost Of Goods Sold 587.63 577.29 478.23 422.14 438.42 380.20 366.24 238.37 262.90 253.46 243.99 Gross Profit 889.20 981.30 712.97 528.94 498.50 382.51 300.59 289.04 315.99 256.52 225.16 GP Margin 60.21% 62.96% 59.85% 55.61% 53.21% 50.15% 45.08% 54.80% 54.59% 50.30% 47.99% Total Expenditure 1,153.58 1,095.99 919.36 808.46 790.09 660.82 608.46 476.98 472.55 429.52 402.53 Power & Fuel Cost - 48.72 48.62 42.21 39.21 32.75 26.81 25.95 25.78 22.24 22.53 % Of Sales - 3.13% 4.08% 4.44% 4.19% 4.29% 4.02% 4.92% 4.45% 4.36% 4.80% Employee Cost - 257.06 201.79 182.47 149.74 123.56 110.46 102.99 92.74 65.38 51.81 % Of Sales - 16.49% 16.94% 19.19% 15.98% 16.20% 16.56% 19.53% 16.02% 12.82% 11.04% Manufacturing Exp. - 107.79 86.94 89.16 77.10 64.84 50.10 55.54 44.90 39.31 43.56 % Of Sales - 6.92% 7.30% 9.37% 8.23% 8.50% 7.51% 10.53% 7.76% 7.71% 9.28% General & Admin Exp. - 60.91 51.22 35.80 38.93 27.75 27.49 33.32 28.30 29.72 23.59 % Of Sales - 3.91% 4.30% 3.76% 4.16% 3.64% 4.12% 6.32% 4.89% 5.83% 5.03% Selling & Distn. Exp. - 33.94 29.58 27.40 34.63 18.30 18.28 14.04 11.16 17.52 14.54 % Of Sales - 2.18% 2.48% 2.88% 3.70% 2.40% 2.74% 2.66% 1.93% 3.44% 3.10% Miscellaneous Exp. - 10.29 22.99 9.28 12.08 13.42 9.08 6.77 6.78 1.89 14.54 % Of Sales - 0.66% 1.93% 0.98% 1.29% 1.76% 1.36% 1.28% 1.17% 0.37% 0.54% EBITDA 323.26 462.59 271.84 142.62 146.82 101.89 58.37 50.43 106.34 80.45 66.62 EBITDA Margin 21.89% 29.68% 22.82% 15.00% 15.67% 13.36% 8.75% 9.56% 18.37% 15.78% 14.20% Other Income 20.51 12.54 9.75 2.08 16.10 3.89 3.49 4.53 1.17 1.78 0.78 Interest 8.30 14.00 13.07 13.50 17.90 21.57 15.66 18.93 21.09 24.48 27.36 Depreciation 65.54 59.70 52.78 49.04 39.68 31.28 25.86 22.10 19.23 15.74 15.32 PBT 346.33 401.44 215.75 82.16 105.33 52.92 20.34 13.93 67.19 42.00 24.72 Tax 86.22 101.36 52.23 18.34 24.70 36.71 3.90 1.87 20.32 14.92 8.79 Tax Rate 24.90% 25.25% 24.21% 22.32% 23.45% 69.37% 19.17% 13.42% 30.24% 35.52% 35.56% PAT 260.10 300.08 163.52 63.82 80.63 16.21 16.44 12.06 46.86 27.33 15.94 PAT before Minority Interest 260.10 300.08 163.52 63.82 80.63 16.21 16.44 12.06 46.86 27.08 15.93 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.25 0.01 PAT Margin 17.61% 19.25% 13.73% 6.71% 8.61% 2.13% 2.47% 2.29% 8.09% 5.36% 3.40% PAT Growth -13.32% 83.51% 156.22% -20.85% 397.41% -1.40% 36.32% -74.26% 71.46% 71.46% EPS 203.20 234.44 127.75 49.86 62.99 12.66 12.84 9.42 36.61 21.35 12.45

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Shareholder's Funds 1,276.54 988.36 835.57 781.88 705.55 695.58 554.78 542.78 184.17 159.83 Share Capital 12.90 12.90 12.90 12.90 12.90 12.90 8.95 8.95 8.95 8.95 Total Reserves 1,263.64 975.46 822.67 768.98 692.64 682.68 234.98 222.97 175.22 150.87 Non-Current Liabilities 120.59 145.22 178.42 168.68 162.21 103.13 145.78 53.83 69.01 54.58 Secured Loans 44.92 74.25 104.25 88.13 77.37 60.72 103.49 29.81 33.40 21.22 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 12.00 12.00 Long Term Provisions 7.13 9.83 11.45 9.10 12.18 11.74 9.87 9.28 6.85 6.38 Current Liabilities 433.80 445.75 368.13 372.96 361.99 331.19 370.38 288.24 270.16 296.76 Trade Payables 198.54 177.99 122.65 156.75 120.00 124.00 129.01 88.64 86.17 111.76 Other Current Liabilities 233.63 244.71 152.05 158.59 71.55 57.33 40.57 47.11 54.90 33.16 Short Term Borrowings 0.00 11.16 92.21 56.98 168.17 149.06 199.20 151.08 123.63 145.80 Short Term Provisions 1.64 11.89 1.21 0.64 2.27 0.80 1.59 1.41 5.47 6.04 Total Liabilities 1,830.93 1,579.33 1,382.12 1,323.52 1,229.75 1,129.90 1,070.94 884.85 523.34 511.17 Net Block 804.63 738.19 747.70 696.92 622.75 511.67 445.01 435.74 138.77 123.07 Gross Block 1,075.84 953.24 913.24 826.45 714.31 575.42 483.45 454.74 291.78 263.65 Accumulated Depreciation 271.22 215.05 165.54 129.53 91.56 63.75 38.44 19.00 153.00 140.58 Non Current Assets 911.46 819.00 802.87 775.34 715.91 676.96 624.22 510.60 210.00 196.04 Capital Work in Progress 45.89 40.57 20.46 17.25 23.75 104.47 126.09 19.60 40.48 41.47 Non Current Investment 1.44 0.68 0.66 19.50 30.33 30.37 30.37 30.36 7.55 7.67 Long Term Loans & Adv. 40.31 20.21 14.40 41.66 35.78 30.45 22.52 24.69 22.71 23.83 Other Non Current Assets 0.17 0.00 0.00 0.00 3.30 0.00 0.22 0.22 0.50 0.00 Current Assets 919.47 760.34 579.25 548.18 513.83 452.93 446.73 374.24 313.34 315.13 Current Investments 0.00 0.00 3.38 6.46 7.50 7.50 7.50 7.50 0.00 0.00 Inventories 350.42 279.23 265.21 247.61 219.55 192.65 175.09 135.11 126.66 113.40 Sundry Debtors 373.53 361.77 234.33 217.73 189.89 164.02 193.92 181.11 119.11 128.85 Cash & Bank 115.29 58.65 18.99 18.08 45.69 37.35 17.05 12.04 9.04 6.49 Other Current Assets 80.23 13.66 11.39 8.76 51.21 51.41 53.17 38.47 58.53 66.39 Short Term Loans & Adv. 61.96 47.03 45.95 49.54 33.79 31.77 36.93 25.03 46.54 45.17 Net Current Assets 485.67 314.59 211.12 175.22 151.84 121.74 76.35 86.00 43.18 18.37 Total Assets 1,830.93 1,579.34 1,382.12 1,323.52 1,229.74 1,129.89 1,070.95 884.84 523.34 511.17

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Shareholder's Funds 1,282.70 994.10 840.50 786.46 709.96 699.31 558.04 545.62 186.63 161.38 Share Capital 12.90 12.90 12.90 12.90 12.90 12.90 8.95 8.95 8.95 8.95 Total Reserves 1,269.80 981.20 827.60 773.56 697.06 686.41 238.24 225.81 177.68 152.42 Non-Current Liabilities 122.17 146.71 179.83 169.82 163.39 104.06 146.43 54.37 69.42 54.76 Secured Loans 44.92 74.25 104.25 88.13 77.37 60.72 103.49 29.81 33.40 21.22 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 12.00 12.00 Long Term Provisions 7.61 10.29 11.91 9.44 12.49 11.91 9.87 9.28 6.85 6.38 Current Liabilities 427.68 438.96 363.16 368.51 357.63 326.98 366.93 285.60 268.00 295.14 Trade Payables 191.96 171.01 117.38 152.13 115.56 119.68 124.29 85.92 83.86 111.81 Other Current Liabilities 234.01 244.87 152.35 158.75 71.63 57.45 41.83 47.18 55.02 31.28 Short Term Borrowings 0.00 11.16 92.21 56.98 168.17 149.06 199.20 151.08 123.63 145.80 Short Term Provisions 1.72 11.93 1.21 0.64 2.27 0.80 1.59 1.41 5.50 6.25 Total Liabilities 1,832.55 1,579.77 1,383.49 1,324.79 1,230.98 1,130.35 1,071.40 885.59 524.05 511.53 Net Block 804.64 738.19 747.70 696.94 622.76 511.69 445.01 435.74 138.77 123.07 Gross Block 1,072.98 950.36 913.27 826.48 714.33 575.44 483.45 454.74 291.78 263.65 Accumulated Depreciation 268.34 212.17 165.57 129.54 91.57 63.75 38.44 19.00 153.00 140.58 Non Current Assets 911.48 818.87 802.70 775.20 715.79 676.88 624.20 510.54 209.87 195.76 Capital Work in Progress 45.89 40.57 20.46 17.25 23.75 104.47 126.09 19.60 40.48 41.47 Non Current Investment 1.28 0.52 0.50 19.35 30.17 30.21 30.21 30.20 7.39 7.39 Long Term Loans & Adv. 40.47 20.24 14.38 41.67 35.81 30.51 22.66 24.79 22.73 23.83 Other Non Current Assets 0.17 0.00 0.00 0.00 3.30 0.00 0.22 0.22 0.50 0.00 Current Assets 921.08 760.89 580.79 549.59 515.19 453.47 447.19 375.04 314.19 315.77 Current Investments 0.00 0.00 3.38 6.46 7.50 7.50 7.50 7.50 0.00 0.00 Inventories 350.42 279.23 265.21 247.61 219.55 192.65 175.09 135.11 126.66 113.40 Sundry Debtors 373.53 361.77 234.33 217.73 189.89 164.02 193.92 181.11 119.11 128.85 Cash & Bank 116.80 59.10 20.36 19.40 46.98 37.84 17.26 12.49 9.71 6.98 Other Current Assets 80.33 13.70 11.52 8.84 51.27 51.46 53.43 38.83 58.70 66.53 Short Term Loans & Adv. 62.03 47.09 46.00 49.55 33.80 31.77 37.15 25.30 46.68 45.23 Net Current Assets 493.40 321.94 217.64 181.08 157.55 126.49 80.27 89.45 46.18 20.63 Total Assets 1,832.56 1,579.76 1,383.49 1,324.79 1,230.98 1,130.35 1,071.39 885.58 524.06 511.53

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Cash From Operating Activity 260.06 238.53 60.41 189.28 56.63 69.60 11.52 38.89 44.65 13.07 PBT 400.77 215.21 81.74 104.96 52.50 19.84 13.54 66.55 41.28 24.48 Adjustment 62.07 77.93 66.18 40.17 58.14 38.93 40.35 43.95 33.85 36.35 Changes in Working Capital -91.22 -11.04 -66.99 49.34 -49.30 15.92 -39.20 -55.25 -18.76 -38.74 Cash after chg. in Working capital 371.63 282.10 80.93 194.47 61.33 74.68 14.69 55.25 56.38 22.08 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -111.57 -43.57 -20.53 -5.19 -4.70 -5.09 -3.17 -16.36 -11.73 -9.01 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -149.67 -61.50 -95.53 -84.42 -48.68 -77.22 -116.29 -42.11 -19.86 -14.13 Net Fixed Assets -127.92 -60.11 -90.00 -105.64 -58.17 -70.35 -135.20 -142.08 -27.14 -12.02 Net Investments -0.76 3.36 21.92 11.87 0.04 0.00 -0.01 -30.31 0.12 -0.03 Others -20.99 -4.75 -27.45 9.35 9.45 -6.87 18.92 130.28 7.16 -2.08 Cash from Financing Activity -69.28 -135.80 37.72 -113.66 -5.48 11.98 104.86 -0.08 -23.62 1.15 Net Cash Inflow / Outflow 41.11 41.24 2.60 -8.80 2.47 4.36 0.09 -3.30 1.18 0.08 Opening Cash & Equivalents 44.96 3.72 1.12 9.92 7.44 3.08 3.00 6.29 0.32 0.23 Closing Cash & Equivalent 86.07 44.96 3.72 1.12 9.92 7.44 3.08 3.00 1.49 0.32

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Cash From Operating Activity 261.18 237.21 60.39 189.36 57.34 69.91 11.27 38.68 44.83 13.17 PBT 401.44 215.75 82.16 105.33 52.92 20.34 13.93 67.19 42.00 24.72 Adjustment 62.08 77.93 66.30 40.08 58.28 39.11 40.43 43.96 33.73 36.34 Changes in Working Capital -90.73 -12.83 -67.58 49.22 -49.17 15.47 -40.02 -55.94 -19.17 -38.76 Cash after chg. in Working capital 372.78 280.84 80.88 194.63 62.03 74.91 14.35 55.20 56.56 22.30 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -111.60 -43.63 -20.49 -5.27 -4.68 -5.01 -3.08 -16.52 -11.73 -9.13 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -149.69 -61.50 -95.52 -84.42 -48.68 -77.23 -116.29 -42.11 -19.86 -14.13 Net Fixed Assets -127.92 -60.11 -90.00 -105.64 -58.17 -70.35 -135.20 -142.08 -27.14 -12.02 Net Investments -0.76 3.36 21.92 11.87 0.04 0.00 -0.01 -30.31 0.12 -0.03 Others -21.01 -4.75 -27.44 9.35 9.45 -6.88 18.92 130.28 7.16 -2.08 Cash from Financing Activity -69.28 -135.80 37.72 -113.66 -5.48 11.98 104.85 -0.09 -23.62 1.15 Net Cash Inflow / Outflow 42.21 39.92 2.59 -8.72 3.18 4.66 -0.17 -3.51 1.35 0.19 Opening Cash & Equivalents 45.42 5.09 2.44 11.20 7.94 3.29 3.44 6.97 0.81 0.62 Closing Cash & Equivalent 87.58 45.42 5.09 2.44 11.20 7.94 3.29 3.44 2.16 0.81

Financial Ratios

Consolidated /

Standalone

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Book Value (Rs.) 994.26 769.65 650.56 608.71 549.21 541.45 273.54 260.03 206.30 178.97 ROA 17.57% 11.02% 4.70% 6.29% 1.35% 1.47% 1.21% 6.59% 5.11% 3.17% ROE 26.48% 17.90% 7.86% 10.81% 2.27% 3.44% 4.98% 22.39% 15.44% 11.25% ROCE 33.62% 20.99% 9.44% 12.83% 7.84% 3.95% 4.04% 15.94% 18.46% 15.74% Fixed Asset Turnover 1.54 1.28 1.09 1.22 1.18 1.26 1.13 1.57 1.86 1.82 Receivable days 86.10 91.33 86.74 79.40 84.68 97.96 129.34 93.22 87.45 94.81 Inventory Days 73.73 83.41 98.40 91.00 98.63 100.64 106.98 81.29 84.66 79.24 Payable days 119.04 114.73 120.79 115.20 67.56 78.05 84.05 68.43 85.33 91.74 Cash Conversion Cycle 40.79 60.01 64.36 55.20 115.76 120.56 152.27 106.08 86.78 82.31 Total Debt/Equity 0.06 0.12 0.28 0.22 0.37 0.33 1.31 0.83 0.99 1.18 Interest Cover 29.63 17.47 7.06 6.86 3.43 2.27 1.72 4.16 2.69 1.90

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Book Value (Rs.) 999.07 774.12 654.40 612.28 552.65 544.35 277.21 263.23 209.07 180.72 ROA 17.59% 11.04% 4.71% 6.31% 1.37% 1.49% 1.23% 6.65% 5.23% 3.20% ROE 26.38% 17.84% 7.85% 10.79% 2.30% 3.48% 5.02% 22.34% 15.64% 11.24% ROCE 33.51% 20.94% 9.44% 12.81% 7.85% 3.99% 4.07% 15.98% 18.57% 15.75% Fixed Asset Turnover 1.54 1.28 1.09 1.22 1.18 1.26 1.13 1.57 1.86 1.82 Receivable days 86.10 91.33 86.74 79.40 84.68 97.96 129.34 93.22 87.45 94.81 Inventory Days 73.73 83.41 98.40 91.00 98.63 100.64 106.98 81.29 84.66 79.24 Payable days 114.75 110.05 116.52 111.44 65.43 75.72 82.06 67.03 85.01 92.70 Cash Conversion Cycle 45.08 64.68 68.63 58.96 117.88 122.89 154.27 107.48 87.10 81.35 Total Debt/Equity 0.06 0.12 0.28 0.22 0.37 0.33 1.30 0.82 0.98 1.17 Interest Cover 29.68 17.51 7.09 6.89 3.45 2.30 1.74 4.19 2.72 1.90

Top Investors:

malabar india fund limited

mukul mahavir agrawal

hsbc focused fund

siddharth iyer

icici prudential flexicap fund

matthews india fund

jupiter india fund

kedia securities private limited

investor education and protection fund (iepf)

Annual Reports:

News Update:

USFDA inspects Neuland Laboratories’ Unit 2 manufacturing facility in Telangana
3rd May 2025, 16:22 PM

The FDA issued Form 483, with one observation related to building and facility management
Read More

Neuland Laboratories Ltd.

Pharmaceuticals & Drugs - API

BSE: 524558 | NSE: NEULANDLAB

Stock Summary

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Earnings Forecasts:

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Consolidated Figures in Rs. Crores /

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Cash Flow

Consolidated Figures in Rs. Crores /

Financial Ratios

Consolidated /

Top Investors:

Annual Reports:

News Update:

Neuland Laboratories Ltd.

Pharmaceuticals & Drugs - API

BSE: 524558 | NSE: NEULANDLAB

Stock Summary

Shareholding Pattern

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Earnings Forecasts:

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Consolidated Figures in Rs. Crores /

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Cash Flow

Consolidated Figures in Rs. Crores /

Financial Ratios

Consolidated /

Top Investors:

Annual Reports:

News Update: